New techniques and strategies in drug discovery
暂无分享,去创建一个
Guan Wang | Zhen Zhang | Jing Guo | Hao Fang | Zhihong Li | Dongwei Kang | Xinyong Liu | Jintong Du | Yihua Zhang | Zhangjian Huang | Li Rao | Peng Zhan | Jianbing Wu | Xuben Hou | Guobo Li | Xiaoyun Lu | Liang Ouyang | Xiaojin Zhang | Dongwei Kang | P. Zhan | Xinyong Liu | L. Ouyang | Guan Wang | Xiaoyun Lu | Yihua Zhang | Xuben Hou | H. Fang | Li Rao | Zhangjian Huang | Xiaojin Zhang | Zhihong Li | Jianbing Wu | Jintong Du | Guobo Li | Jing Guo | Zhen Zhang | Ouyang Liang | Guo-Bo Li
[1] Hong Cao,et al. HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants. , 2008, Journal of the American Chemical Society.
[2] Zhangjian Huang,et al. Nanoscale Coordination Polymers for Synergistic NO and Chemodynamic Therapy of Liver Cancer. , 2019, Nano letters.
[3] Hening Lin,et al. Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model. , 2019, Journal of medicinal chemistry.
[4] R. Jackson,et al. Towards a structural classification of phosphate binding sites in protein–nucleotide complexes: An automated all‐against‐all structural comparison using geometric matching , 2004, Proteins.
[5] Wiktor Szymanski,et al. Recent developments in reversible photoregulation of oligonucleotide structure and function. , 2017, Chemical Society reviews.
[6] R. Roskoski. Properties of FDA-approved small molecule protein kinase inhibitors. , 2019, Pharmacological research.
[7] Dirk Trauner,et al. In Vivo Photopharmacology. , 2018, Chemical reviews.
[8] Lirong Wang,et al. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research , 2017, J. Chem. Inf. Model..
[9] Wenping Guo,et al. XO: An extended ONIOM method for accurate and efficient modeling of large systems , 2012, J. Comput. Chem..
[10] Katrina T Forest,et al. Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid. , 2018, Journal of the American Chemical Society.
[11] Jan Grimm,et al. Photoactivatable Prodrug of Doxazolidine Targeting Exosomes. , 2019, Journal of medicinal chemistry.
[12] Paul Edison,et al. Drug repositioning for Alzheimer's disease , 2012, Nature Reviews Drug Discovery.
[13] Hening Lin,et al. A Small‐Molecule SIRT2 Inhibitor That Promotes K‐Ras4a Lysine Fatty‐Acylation , 2019, ChemMedChem.
[14] Dong Hang,et al. Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer. , 2017, Gene.
[15] W. M. Atkins,et al. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases , 2005, Cellular and Molecular Life Sciences CMLS.
[16] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[17] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[18] Xiaofeng Liu,et al. SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening , 2011, J. Chem. Inf. Model..
[19] V. Promponas,et al. iLIR database: A web resource for LIR motif-containing proteins in eukaryotes , 2016, Autophagy.
[20] Peter Fristrup,et al. Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH* , 2016, The Journal of Biological Chemistry.
[21] Hongying Gao,et al. Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors. , 2019, Journal of medicinal chemistry.
[22] Rakesh Kumar,et al. Reflecting Back to Bring Nitric Oxide Research to the Laboratory. , 2016, Current medicinal chemistry.
[23] R. Chari,et al. Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.
[24] S. Sarafianos,et al. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H. , 2019, Accounts of chemical research.
[25] Matthias Rarey,et al. Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening , 2014, J. Chem. Inf. Model..
[26] C. Venkatachalam,et al. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.
[27] Stephen H Hughes,et al. Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors , 2017, Journal of medicinal chemistry.
[28] Verónica San Miguel,et al. Wavelength-selective caged surfaces: how many functional levels are possible? , 2011, Journal of the American Chemical Society.
[29] I. E. Smith,et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. , 2015, Nature chemical biology.
[30] Guo-Bo Li,et al. IFPTarget: A Customized Virtual Target Identification Method Based on Protein-Ligand Interaction Fingerprinting Analyses , 2017, J. Chem. Inf. Model..
[31] Hening Lin,et al. HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine. , 2016, ACS chemical biology.
[32] Wiktor Szymanski,et al. Wavelength-selective cleavage of photoprotecting groups: strategies and applications in dynamic systems. , 2015, Chemical Society reviews.
[33] Peng Zhan,et al. Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant. , 2018, Journal of medicinal chemistry.
[34] O. Wiest,et al. On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. , 2004, Journal of medicinal chemistry.
[35] Semih Otles,et al. Nitration of tyrosine and its effect on DNA hybridization. , 2018, Biosensors & bioelectronics.
[36] Simone Mocellin,et al. Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities , 2007, Medicinal research reviews.
[37] Peng Zhan,et al. Discovery and Characterization of Fluorine-Substituted Diarylpyrimidines Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel. , 2020, Journal of medicinal chemistry.
[38] Aniko Simon,et al. eHiTS: a new fast, exhaustive flexible ligand docking system. , 2007, Journal of molecular graphics & modelling.
[39] Benjamin E. L. Lauffer,et al. Cell Viability Cellular Histone Acetylation but Not Kinetic Rate Constants Correlate with Histone Deacetylase ( HDAC ) Inhibitor Cell Biology : , 2013 .
[40] Peng Zhan,et al. Overview of Recent Strategic Advances in Medicinal Chemistry. , 2019, Journal of medicinal chemistry.
[41] John M Denu,et al. Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins* ♦ , 2013, The Journal of Biological Chemistry.
[42] Wiktor Szymanski,et al. Photopharmacology: beyond proof of principle. , 2014, Journal of the American Chemical Society.
[43] Xiaofeng Liu,et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method , 2013, Bioinform..
[44] P. Srinivas,et al. Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers. , 2016, Critical reviews in oncology/hematology.
[45] Qidong You,et al. Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light. , 2019, Journal of medicinal chemistry.
[46] A. Hamacher-Brady,et al. Agent-based modeling of autophagy reveals emergent regulatory behavior of spatio-temporal autophagy dynamics , 2014, Cell Communication and Signaling.
[47] Hans Bitter,et al. The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 , 2017, Nature.
[48] Irene T Weber,et al. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. , 2008, Accounts of chemical research.
[49] Hening Lin,et al. SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context. , 2016, ACS chemical biology.
[50] Nese Kurt Yilmaz,et al. HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands to Optimize Hydrogen Bonding in the Substrate Envelope. , 2019, Journal of medicinal chemistry.
[51] M. Resh,et al. Fatty acylation of proteins: The long and the short of it. , 2016, Progress in lipid research.
[52] Peng Zhan,et al. Molecular design opportunities presented by solvent‐exposed regions of target proteins , 2019, Medicinal research reviews.
[53] L. Keefer,et al. Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives. , 2002, Chemical reviews.
[54] M. Clausen,et al. Allosteric small-molecule kinase inhibitors. , 2015, Pharmacology & therapeutics.
[55] Yuda Huang,et al. Protein Tyrosine Nitration in Lung Cancer: Current Research Status and Future Perspectives. , 2018, Current medicinal chemistry.
[56] Hening Lin,et al. Activity-Guided Design of HDAC11-Specific Inhibitors. , 2019, ACS chemical biology.
[57] Peng Zhan,et al. Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles. , 2019, Journal of medicinal chemistry.
[58] Richard M. Jackson,et al. ReverseScreen3D: A Structure-Based Ligand Matching Method To Identify Protein Targets , 2011, J. Chem. Inf. Model..
[59] Dariusz Plewczynski,et al. Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database , 2011, J. Comput. Chem..
[60] S. Emr,et al. Autophagy as a regulated pathway of cellular degradation. , 2000, Science.
[61] Yu-Hang Yan,et al. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. , 2018 .
[62] Yong Xu,et al. A combined molecular docking-based and pharmacophore-based target prediction strategy with a probabilistic fusion method for target ranking. , 2013, Journal of molecular graphics & modelling.
[63] S. Glynn,et al. The yin and yang of nitric oxide in cancer progression. , 2013, Carcinogenesis.
[64] Hening Lin,et al. Identifying the functional contribution of the defatty-acylase activity of SIRT6 , 2016, Nature chemical biology.
[65] Brian C. Smith,et al. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide. , 2007, Biochemistry.
[66] Lyle Wallis,et al. A multimethod computational simulation approach for investigating mitochondrial dynamics and dysfunction in degenerative aging , 2017, Aging cell.
[67] Zhangjian Huang,et al. Glutathione S-Transferase π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo. , 2018, Journal of medicinal chemistry.
[68] Michael S Janes,et al. Nitration of Hsp90 on Tyrosine 33 Regulates Mitochondrial Metabolism* , 2015, The Journal of Biological Chemistry.
[69] P. Carter,et al. Antibody-drug conjugates in cancer therapy. , 2013, Annual review of medicine.
[70] Peng Zhan,et al. Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. , 2017, Journal of medicinal chemistry.
[71] Hening Lin,et al. SIRT7 Is an RNA-Activated Protein Lysine Deacylase. , 2017, ACS chemical biology.
[72] A. Matsuda,et al. Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. , 2016, Journal of medicinal chemistry.
[73] Wiktor Szymanski,et al. Photoactivation of MDM2 Inhibitors: Controlling Protein–Protein Interaction with Light , 2018, Journal of the American Chemical Society.
[74] Melissa M. Reynolds,et al. Applications for nitric oxide in halting proliferation of tumor cells. , 2013, Biochemical and biophysical research communications.
[75] Peng Zhan,et al. Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017) , 2018, Expert opinion on therapeutic patents.
[76] Yi Wang,et al. Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine , 2013, Nature.
[77] Erik De Clercq,et al. A cutting-edge view on the current state of antiviral drug development. , 2013 .
[78] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[79] Weiliang Zhu,et al. D3Pockets: A Method and Web Server for Systematic Analysis of Protein Pocket Dynamics , 2019, J. Chem. Inf. Model..
[80] E. Seto,et al. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention , 2007, Oncogene.
[81] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[82] Minoru Yoshida,et al. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation. , 2015, Biochemistry.
[83] Wei Huang,et al. Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants. , 2017, Journal of medicinal chemistry.
[84] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[85] Thomas P Davis,et al. Delivering nitric oxide with nanoparticles. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[86] Jian Wan,et al. Conformation Search Across Multiple-Level Potential-Energy Surfaces (CSAMP): A Strategy for Accurate Prediction of Protein-Ligand Binding Structures. , 2019, Journal of chemical theory and computation.
[87] Shaoyong Lu,et al. Discovery of hidden allosteric sites as novel targets for allosteric drug design. , 2017, Drug discovery today.
[88] Peng Zhan,et al. Designed multiple ligands: an emerging anti-HIV drug discovery paradigm. , 2009, Current pharmaceutical design.
[89] Rob Leurs,et al. Photoswitching the Efficacy of a Small-Molecule Ligand for a Peptidergic GPCR: from Antagonism to Agonism. , 2018, Angewandte Chemie.
[90] X Liu,et al. Rationally designed multitarget anti-HIV agents. , 2013, Current medicinal chemistry.
[91] Jianfeng Pei,et al. Systems biology brings new dimensions for structure-based drug design. , 2014, Journal of the American Chemical Society.
[92] Mingwei Jin,et al. Bioinformatic analysis of Cacybp‐associated proteins using human glioma databases , 2019, IUBMB life.
[93] E. Kellenberger,et al. A simple and fuzzy method to align and compare druggable ligand‐binding sites , 2008, Proteins.
[94] Gooitzen M van Dam,et al. Emerging Targets in Photopharmacology. , 2016, Angewandte Chemie.
[95] Peng Zhan,et al. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles. , 2016, Journal of medicinal chemistry.
[96] Peng Zhan,et al. Multivalent agents: a novel concept and preliminary practice in Anti-HIV drug discovery. , 2013, Current medicinal chemistry.
[97] K. M. Davies,et al. The secondary amine/nitric oxide complex ion R(2)N[N(O)NO](-) as nucleophile and leaving group in S9N)Ar reactions. , 2001, The Journal of organic chemistry.
[98] Martin O. Leach,et al. Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers , 2014, Clinical Cancer Research.
[99] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[100] Hening Lin,et al. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. , 2016, Cancer cell.
[101] Lin-Li Li,et al. ID-Score: A New Empirical Scoring Function Based on a Comprehensive Set of Descriptors Related to Protein-Ligand Interactions , 2013, J. Chem. Inf. Model..
[102] H. Chakrapani,et al. INDQ/NO, a bioreductively activated nitric oxide prodrug. , 2013, Organic letters.
[103] G. Schneider,et al. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. , 2019, Chemical reviews.
[104] S. Rice,et al. Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms. , 2012, Angewandte Chemie.
[105] D. Wink,et al. Biological signaling by small inorganic molecules. , 2016, Coordination chemistry reviews.
[106] Raman Parkesh,et al. AutophagySMDB: a curated database of small molecules that modulate protein targets regulating autophagy , 2019, Autophagy.
[107] M. K. Pflum,et al. Mutagenesis Studies of the 14 Å Internal Cavity of Histone Deacetylase 1: Insights toward the Acetate-Escape Hypothesis and Selective Inhibitor Design , 2014, Journal of medicinal chemistry.
[108] Peng Zhan,et al. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant. , 2018, Journal of medicinal chemistry.
[109] Kathryn A. Porter,et al. Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases. , 2019, Journal of medicinal chemistry.
[110] P. Atadja,et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. , 2011, Bioorganic & medicinal chemistry.
[111] Rob Leurs,et al. Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology , 2018, Journal of the American Chemical Society.
[112] Peng Zhan,et al. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase. , 2018, European journal of medicinal chemistry.
[113] Xiaomin Luo,et al. KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules , 2019, Bioinform..
[114] Christian Peifer,et al. Photoactivatable Prodrugs of Antimelanoma Agent Vemurafenib. , 2015, ACS chemical biology.
[115] David D. Anderson,et al. Enhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug‐Resistant HIV† , 2012, Angewandte Chemie.
[116] Hualiang Jiang,et al. SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration. , 2011, Journal of medicinal chemistry.
[117] Junjie Fu,et al. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects. , 2017, Journal of medicinal chemistry.
[118] Tao He,et al. Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors. , 2017, European journal of medicinal chemistry.
[119] F. Lombardo,et al. Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1. , 2018, Journal of medicinal chemistry.
[120] Peng Zhan,et al. Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV‐1 RNase H inhibitors , 2019, Chemical biology & drug design.
[121] Nathanael S Gray,et al. Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations , 2019, Nature Communications.
[122] Emmanuelle Thinon,et al. Proteomic analysis of fatty-acylated proteins. , 2016, Current opinion in chemical biology.
[123] Pedro Cabrales,et al. Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC , 2016, Respiratory medicine case reports.
[124] Qiang Yang,et al. Targeted delivery of nitric oxide via a ‘bump-and-hole’-based enzyme–prodrug pair , 2018, Nature Chemical Biology.
[125] Michal Wozniak,et al. Nitric oxide and its derivatives in the cancer battlefield. , 2019, Nitric oxide : biology and chemistry.
[126] A. Hauschild,et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. , 2015, The New England journal of medicine.
[127] Zsofia Kutil,et al. Histone Deacetylase 11 Is a Fatty-Acid Deacylase. , 2018, ACS chemical biology.
[128] Guo-Bo Li,et al. LEADOPT: an automatic tool for structure-based lead optimization, and its application in structural optimizations of VEGFR2 and SYK inhibitors. , 2015, European journal of medicinal chemistry.
[129] Tingting Wang,et al. Synthesis and Evaluation of O2-Derived Diazeniumdiolates Activatable via Bioorthogonal Chemistry Reactions in Living Cells. , 2018, Organic letters.
[130] Cheng Luo,et al. Computational methods for drug design and discovery: focus on China , 2013, Trends in Pharmacological Sciences.
[131] Ajay N. Jain. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.
[132] Peng Zhan,et al. Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends. , 2016, Journal of medicinal chemistry.
[133] Yongjian Li,et al. DOX: A new computational protocol for accurate prediction of the protein–ligand binding structures , 2016, J. Comput. Chem..
[134] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[135] Hening Lin,et al. The Substrate Specificity of Sirtuins. , 2016, Annual review of biochemistry.
[136] Min Wang,et al. Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma. , 2019, Cancer research.
[137] Peng Zhan,et al. Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties. , 2019, Journal of medicinal chemistry.
[138] Zhangjian Huang,et al. Design, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-Transferase. , 2016, Organic letters.
[139] Fangfang Zhang,et al. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library. , 2018, European journal of medicinal chemistry.